Abstract:Background: The chromodomain helicase DNA binding domain (CHD) proteins modulate gene expression via their ability to remodel chromatin structure and influence histone acetylation. Recent studies have shown that CHD2 protein plays a critical role in embryonic development, tumor suppression and survival. Like other genes encoding members of the CHD family, pathogenic mutations in the CHD2 gene are expected to be implicated in human disease. In fact, there is emerging evidence suggesting that CHD2 might contribute to a broad spectrum of neurodevelopmental disorders. Despite growing evidence, a description of the full phenotypic spectrum of this condition is lacking. Methods: We conducted a multicentre study to identify and characterise the clinical features associated with haploinsufficiency of CHD2. Patients with deletions of this gene were identified from among broadly ascertained clinical cohorts undergoing genomic microarray analysis for developmental delay, congenital anomalies and/or autism spectrum disorder. Results: Detailed clinical assessments by clinical geneticists showed recurrent clinical symptoms, including developmental delay, intellectual disability, epilepsy, behavioural problems and autism-like features without characteristic facial gestalt or brain malformations observed on magnetic resonance imaging scans. Parental analysis showed that the deletions affecting CHD2 were de novo in all four patients, and analysis of high-resolution microarray data derived from 26,826 unaffected controls showed no deletions of this gene. Conclusions: The results of this study, in addition to our review of the literature, support a causative role of CHD2 haploinsufficiency in developmental delay, intellectual disability, epilepsy and behavioural problems, with phenotypic variability between individuals.

Chromatin gatekeeper and modifier CHD proteins in development, and in autism and other neurological disorders

Chromodomain Helicase DNA-Binding Proteins in Stem Cells and Human Developmental Diseases

Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease

Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders

Characterization of the CHD family of proteins

The CHD Protein, Kismet, is Important for the Recycling of Synaptic Vesicles during Endocytosis

Genetic Variability of the Functional Domains of Chromodomains Helicase DNA-Binding (CHD) Proteins

The ChAHP chromatin remodelling complex regulates neurodevelopmental disorder risk genes to scale the production of neocortical layers

Intrinsically Disordered Regions Define Unique Protein Interaction Networks in CHD Family Remodelers

Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation

Versatile Roles of the Chromatin Remodeler CHD7 during Brain Development and Disease.

Chd7 is Indispensable for Mammalian Brain Development Through Activation of a Neuronal Differentiation Programme

Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration

The chromatin remodeler CHD3 is highly expressed in mature neurons and regulates genes involved in synaptic development and function

Chromatin Remodeling BAF (SWI/SNF) Complexes in Neural Development and Disorders

CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems

Regulation of sensory perception and motor abilities by brain-specific action of chromatin remodeling factor CHD1

Chd2 Is Necessary for Neural Circuit Development and Long-Term Memory

The role of the polybromo-associated BAF complex in development

Variations in Chromatin Architectural Proteins in Human Diseases

The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer